Avoro Capital Advisors LLC Portfolio Holdings

Avoro Capital Advisors LLC

  • $6.65 Billion
  • Q3 2024

Avoro Capital Advisors LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $6.65 Billion distributed in 36 stocks.

Among their holdings, we can observe that their the top five positions include companies like: United Therapeutics Corp with a value of $1.02B, Ascendis Pharma A/S with a value of $745M, Argenx Se with a value of $672M, Krystal Biotech, Inc. with a value of $477M, and Madrigal Pharmaceuticals, Inc. with a value of $431M.

Examining the 13F form we can see an decrease of $680M in the current position value, from $7.33B to 6.65B.

Avoro Capital Advisors LLC is based out at New York, NY

Below you can find more details about Avoro Capital Advisors LLC portfolio as well as his latest detailed transactions.

Portfolio value $6.65 Billion
Healthcare: $6.65 Billion

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 36
  • Current Value $6.65 Billion
  • Prior Value $7.33 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 0 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email